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Editorial
Human-animal chimeras: circumventing rather than
discussing ethical concerns comes at a price
This issue of RBMOnline features a highly interesting paper on chi-
meras intended for human gamete production by philosopher César
Palacios-González (2017). The paper breaks new ground by linking
two ethically charged scientific developments. Whilst several groups
are aiming to create stem cell-derived gametes through tissue culture
in the laboratory (Hendriks et al., 2015), others are working on
interspecies chimeras as a possible future route to obtaining human
stem cell-derived organs from animals, both for research and for
transplantation purposes. This involves a technology called blasto-
cyst complementation, where human induced pluripotent stem cells
(iPS) are injected into animal (e.g. pig) blastocysts that have been modi-
fied genetically to be deficient in a specific organogenetic pathway
(Wu et al., 2016). Using the animal’s developmental environment may
be a more promising route for growing human organs than tissue
culture. Although, at least in theory, human-animal chimeras might
also be used for growing human gametes, this has not until now been
proposed or discussed in the literature. In fact, those working on the
idea of interspecies chimeras have only discussed the unintended de-
velopment of human gametes in animals as something to be avoided
when using this route for obtaining human organs. This avoidance
might require either genetic modification of the human iPS used for
chimera creation (knocking out genes contributing to gametogen-
esis), or the use of a targeted approach in which human adult stem
cells are injected into modified animal embryos at an early in-vivo
stage (Rashid et al., 2014). It is argued that such measures would be
needed to make the growing of human organs in chimeric animals
ethically acceptable.
As Palacios-González (2017) may be right to comment, the pre-
sumption that the very idea of human gametes growing in animals
is ethically problematic seems to stand in the way of even consid-
ering whether blastocyst complementation might be an alternative
to creating human gametes in the laboratory. Of course, if there are
scientific reasons why this option cannot be taken seriously from the
outset, it is a different matter. But were it the case, one would expect
this to have been discussed in the literature. Otherwise, what we see
here is a form of practical self-censorship on the part of the scien-
tific community that is in the interest of neither science, nor society.
It may seem pragmatic to proactively take account of possible soci-
etal concerns and try to work around them, but the consequence is
that presumed ethical barriers to what may be important develop-
ments are taken for granted and not tested by argumentation. With
regard to the ethics of growing human gametes in chimeric animals,
the question should be whether any possible concerns amount to valid
reasons for not pursuing this route. In his contribution to this issue,
Palacios-González convincingly argues that this ethical case cannot
be made, at least with regard to creating human oocytes for re-
search purposes. The issue is a pressing one, as human eggs for basic,
fertility, and stem-cell research are in short supply. Many experi-
ments that require their use cannot be carried out at present, and
so the potential benefits that could emerge from such experiments
are either delayed or never materialise. This state of affairs is prob-
lematic for scientists and patients worldwide.
Of the four possible counterarguments against the use of this tech-
nology for producing human oocytes that Palacios-González considers,
the most challenging objection is animal welfare. Here, the ethical
argument depends on considerations of proportionality (balance of
benefits and harms) and subsidiarity (the requirement that there are
no alternative ways to obtain the expected benefits). Although the sub-
sidiarity requirement is being met at the moment, this may change
if efforts to create human oocytes in vitro prove successful. It there-
fore remains important to also pursue that alternative. With regard
to proportionality, it should be noted that in his paper Palacios-
González limits himself to discussing oocyte creation for research
purposes, further specifying this as research that can be expected
to lead to therapies that would save human lives or reduce human
suffering. But what about using animals for creating human gametes
intended for reproduction? Here the assessment of proportionality
would require further discussion of whether the aim of helping people
to have their own genetic offspring is of sufficient moral weight to
justify the inevitable infringement upon animal wellbeing. On the
‘harms’ side, further fine-tuning of the argument will depend on which
animal species is most suited as host.
Palacios-González’s paper can be read as a timely warning to gov-
ernments and regulators not to follow the suggestion to only allow
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human organ or tissue creation in chimeras on the condition that no
animals capable of developing human gametes will be produced, as
this would block a possibly fruitful and ethically acceptable route to
overcoming the present shortage of oocytes for medical research. The
fear that mating by these animals might otherwise lead to hybrid or
human conceptuses in animal wombs does not require this condi-
tion, as their mating can be easily prevented. Interestingly, the same
line of argument (no unnecessary barriers to scientific develop-
ment) can be used to question a second condition proposed by the
pioneers of the organ creation scenario. This concerns the possibil-
ity that human cells would contribute to brain development in the
chimeric animal. The hypothetical scenario that this would lead to an
animal with human cognitive capacities created to serve as a mere
source of organs or tissues would certainly raise ethical red flags.
Palacios-González rightly observes that if objections based on ‘dignity’
have any leverage it must be with regard to this scenario. In order
to preempt concerns about this, he supports the proposal to pre-
clude the generation of human brain cells through genetic modification
of the human iPS used for blastocyst complementation (Rashid et al.,
2014). However, the wisdom of making this a condition without further
argument can be questioned on similar grounds as put forward in
his paper with regard to excluding gamete creation.
How realistic is it to suppose that even an intended colonization
of animal brain development by human cells would lead to a being
with human cognitive capacities? Commentators have pointed out that
even if human neural progenitors were to take over, the full devel-
opment of human neural structures would require larger skulls and
longer gestation periods than are found in mice or pig (Bourret et al.,
2016; Karpowicz et al., 2005). If this is the case, imposing the ‘no-
contribution-to-brain-development’ condition might make important
potential research applications impossible for no good reason. One
might perhaps think here of developing human brain disease models
in mice, for instance to study amyotrophic lateral sclerosis or other
neurodegenerative disorders. If this research is blocked to address
concerns about a scenario that is not just hypothetical but com-
pletely unrealistic, the same conclusion would seem to follow as with
regard to ruling out gamete development in chimeras. The least one
should say is that before imposing such conditions, a careful discus-
sion of the implications is required.
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